|
Kimia Biosciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
171.98 Cr.
|
P/BV
|
10.10
|
Book Value (Rs.)
|
3.60
|
|
52 Week High/Low (Rs.)
|
87/23
|
FV/ML
|
1/1
|
P/E(X)
|
17.89
|
|
Bookclosure
|
28/09/2020
|
EPS (Rs.)
|
2.03
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | 2.03 | -1.12 | -1.98 |
| Diluted EPS (Rs.) | 2.03 | -1.12 | -1.98 |
| Cash EPS (Rs.) | 2.75 | -0.42 | -1.27 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 2.11 | 0.06 | 1.15 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 2.11 | 0.06 | 1.15 |
| Revenue From Operations / Share (Rs.) | 25.13 | 22.17 | 27.16 |
| PBDIT / Share (Rs.) | 4.56 | 0.24 | -0.79 |
| PBIT / Share (Rs.) | 3.84 | -0.45 | -1.50 |
| PBT / Share (Rs.) | 2.88 | -1.52 | -2.62 |
| Net Profit / Share (Rs.) | 2.03 | -1.12 | -1.98 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 18.13 | 1.10 | -2.92 |
| PBIT Margin (%) | 15.29 | -2.03 | -5.52 |
| PBT Margin (%) | 11.46 | -6.84 | -9.63 |
| Net Profit Margin (%) | 8.08 | -5.06 | -7.27 |
| Return on Networth / Equity (%) | 96.45 | -1603.83 | -171.19 |
| Return on Capital Employeed (%) | 61.90 | -6.98 | -15.79 |
| Return On Assets (%) | 8.64 | -5.31 | -7.70 |
| Long Term Debt / Equity (X) | 1.04 | 64.68 | 5.64 |
| Total Debt / Equity (X) | 3.27 | 131.12 | 9.69 |
| Asset Turnover Ratio (%) | 1.13 | 0.94 | 1.11 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 0.92 | 0.88 | 1.08 |
| Quick Ratio (X) | 0.49 | 0.44 | 0.45 |
| Inventory Turnover Ratio (X) | 3.64 | 2.65 | 3.01 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 4.73 | 0.22 | -0.88 |
| Interest Coverage Ratio (Post Tax) (%) | 3.11 | -0.05 | -0.95 |
| | | | |
| VALUATION RATIOS | | | |
| | | | |
| Enterprise Value (Cr.) | 239.34 | 312.35 | 211.52 |
| EV / Net Operating Revenue (X) | 2.01 | 2.98 | 1.65 |
| EV / EBITDA (X) | 11.10 | 269.64 | -56.21 |
| MarketCap / Net Operating Revenue (X) | 1.69 | 2.51 | 1.20 |
| Price / BV (X) | 20.18 | 797.28 | 28.15 |
| Price / Net Operating Revenue (X) | 1.69 | 2.51 | 1.20 |
| EarningsYield | 0.04 | -0.02 | -0.06 |
